ArticleActa pharmaceutica Sinica. B2026
Identification of a small-molecule targeting PLAGL2 DNA-binding domain inhibits extracellular matrix formation and enhances lenvatinib sensitivity in hepatocellular carcinoma.
Weiwei Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.